A carregar...

GRIK1 Genotype Moderates Topiramate's Effects on Daily Drinking Level, Expectations of Alcohol's Positive Effects, and Desire to Drink

We (Kranzler et al. 2014) reported that topiramate 200 mg/day reduced heavy drinking days and increased abstinent days in 138 heavy drinkers whose treatment goal was to reduce drinking to safe levels. In that 12-week, placebo-controlled study, we measured drinking using the Timeline Follow-back meth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kranzler, Henry R., Armeli, Stephen, Feinn, Richard, Tennen, Howard, Gelernter, Joel, Covault, Jonathan
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4161658/
https://ncbi.nlm.nih.gov/pubmed/24786948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1461145714000510
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!